Answers are grounded in this paper and cite their sources.
Background: Cytokines activate MLK3 to compromise mitochondrial integrity and promote pancreatic cell death. Results: Results suggest a model in which IL-1/TRAF6-mediated Lys-63-linked ubiquitination of MLK3 dissociates monomeric MLK3 from JIP1 for subsequent dimerization and activation. Conclusion: IL-1-stimulated Lys-63-linked ubiquitination activates MLK3, most likely by altering the dynamics of MLK-JNK-JIP module. Significance: These findings can be exploited for therapeutic intervention in diabetes. The mixed lineage kinase MLK3 plays a crucial role in compromising mitochondrial integrity and functions as a proapoptotic competence factor in the early stages of cytokine-induced pancreatic cell death. In an effort to identify mechanisms that regulate MLK3 activity in cells, we discovered that IL-1 stimulates Lys-63-linked ubiquitination of MLK3 via a conserved, TRAF6-binding peptapeptide motif in the catalytic domain of the kinase. TRAF6-mediated ubiquitination was required for dissociation of inactive monomeric MLK3 from the scaffold protein IB1/JIP1, facilitating the subsequent dimerization, autophosphorylation, and catalytic activation of MLK3. Inability to ubiquitinate MLK3, or the presence of A20, an upstream Lys-63-linked deubiquitinase, strongly curtailed the ability of MLK3 to affect the proapoptotic translocation of BAX in cytokine-stimulated pancreatic cells, an early step in the progression toward cell death. These studies suggest a novel mechanism for MLK3 activation and provide new clues for therapeutic intervention in promoting cell survival.
No takes yet. Share an insight, caveat, or question.
Humphrey et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: